Keiji AI is a cutting-edge AI company focused on transforming clinical trials and drug discovery through generative AI technology. With its platform TrialMind, Keiji AI leverages large language models and multimodal AI to generate comprehensive insights for pharmaceutical companies, enabling more efficient trial designs and patient outcomes. The company is led by founders from the University of Illinois Urbana-Champaign, who bring deep technical expertise to the healthcare sector. Keiji AI serves top pharmaceutical companies and is dedicated to advancing innovation in clinical research.